… Correspondence to Bert Vander Cruyssen, Department of Rheumatology, SJK Hospital
Bornem, Kasteelstraat 23, 2880 Bornem, Belgium. Tel: +32 3 296 91 71; e-mail: [email …

… Bert Vander Cruyssen was supported by a concerted action grant GOA 2001/12051501
of the Ghent University, Belgium. The work of Leen De Rycke is supported by the “Vlaams …

… If the 95% intervals obtained from Datasets A and B were found to be overlapping, the
estimate was considered as ‘confirmed’ [12]. Ordinal data were expressed in frequencies per …

Objectives To create a model that provides a potential basis for candidate selection for anti-tumour
necrosis factor (TNF) treatment by predicting future outcomes relative to the current …

Background This study examined whether fecal calprotectin can be used in daily practice as
a marker to monitor patients with ulcerative colitis (UC) receiving infliximab maintenance …

… and fifth digit, and in (B) where almost all interphalangeal joints of both hands were affected
and disabled. Remodelling of the interphalangeal joints in (B) after the erosive process is …

Objectives To compare the efficacy and safety of intensive combination strategies with
glucocorticoids (GCs) in the first 16 weeks (W) of early rheumatoid arthritis (eRA) treatment, …

… Bert Vander Cruyssen1, … Bert Vander Cruyssen … Bert Vander Cruyssen was
supported by a concerted action grant GOA 2001/12051501 from Ghent University, Belgium. …

Aim: To evaluate the effect of infliximab induction therapy on calprotectin levels in patients
with ulcerative colitis (UC). Patients and Methods: In this prospective study 53 patients with …

Objective Hand osteoarthritis is a prevalent disease with limited treatment options. Since
joint inflammation is often present, we investigated tumour necrosis factor (TNF) as treatment …